Potential for Larger Gene Panels to Increase the Number of Molecularly Matched Therapies in Patients with Advanced Solid Tumours By Ogkologos - April 22, 2025 502 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ProfiLER-02 study Source RELATED ARTICLESMORE FROM AUTHOR ESMO’s Special Consultative Status with United Nations Economic and Social Council (UN ECOSOC) Confirmed Until 2028 EMA Recommends Extension of Indications for Selumetinib ESMO Calls for Urgent Changes to the in Vitro Diagnostic Medical Devices Regulation (IVDR) in Order to Safeguard Cancer Research in Europe MOST POPULAR American tobacco company Philip Morris International offers £1bn for UK pharma... July 9, 2021 TILs Therapy Shows Promise in the Management of Anti-PD-1-Resistant Metastatic NSCLC August 23, 2021 FDA Approves Toripalimab-tpzi for Nasopharyngeal Carcinoma November 13, 2023 Higher Pregnancy Rates and No Impact on Prognosis with Embryo/Oocyte Cryopreservation... June 26, 2024 Load more HOT NEWS How a Musician Copes With Life With Metastatic Breast Cancer Analyzing Tumor RNA May Help Match Patients with Most Effective Cancer... Happy New Year From Our Team Reassuring Results Observed with Shorter Duration of Adjuvant Trastuzumab in HER2-positive...
